Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESA LABORATORIES INC /CO/ Director's Dealing 2021

Sep 1, 2021

33153_dirs_2021-09-01_1d9afbd2-8b7f-4568-945b-9eaf8ca49dff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-09-01

Reporting Person: Sakys John (CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-01 Restricted Stock Units - 3 $ A 1537 Acquired Common Stock (1537) Direct
2021-09-01 Restricted Stock Units - 4 $ A 1303 Acquired Common Stock (1303) Direct
2021-09-01 Non Qualified Stock Options $268.85 A 4933 Acquired 2027-09-01 Common Stock (4933) Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock

F2: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024

F3: Not Applicable

F4: RSUs granted for navigation of the Company through Covid-19

F5: RSUs that cliff vest on September 1, 2022

F6: NSOs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024